Calcium supplements: too much of a good thing?
May 31, 2010 by admin · Leave a Comment
Contact: Shari Leventhal
sleventhal@asn-online.org
202-416-0658
American Society of Nephrology Read more
Immune system helps transplanted stem cells navigate in central nervous system
Contact: Tom Vasich
tmvasich@uci.edu
949-824-6455
University of California - Irvine Read more
A prognostic and predictive biomarker for nonsmall cell lung cancer
May 31, 2010 by admin · Leave a Comment
Contact: Marcia Triunfol
mtriunfol@gmail.com
55-248-142-0202
Publicase Comunicação Científica Read more
New technique reliably detects enzyme implicated in cancer and atherosclerosis
May 31, 2010 by admin · Leave a Comment
Contact: John Toon
jtoon@gatech.edu
404-894-6986
Georgia Institute of Technology Research News
An enzyme implicated in osteoporosis, arthritis, atherosclerosis and cancer metastasis cathepsin K — eluded reliable detection in laboratory experiments in the past. Now, a research team at the Georgia Institute of Technology has developed an assay that reliably detects and quantifies mature cathepsin K using a technique called gelatin zymography.
New tool for pre-surgical detection of kidney cancers may help patients avoid unnecessary surgeries
May 31, 2010 by admin · Leave a Comment
Contact: Diana Quattrone
Diana.Quattrone@fccc.edu
215-728-7784
Fox Chase Cancer Center
SAN FRANCISCO, CA. (June 1, 2010)Kidney cancer is a radiographic diagnosis which means treatment decisions are often made based on the findings of a solid mass on CT or MRI. Unfortunately these tests cannot distinguish the different types of kidney cancers which have variable risks. As more Americans continue to be scanned as part of their evaluation for various ailments and symptoms, the number of kidney tumors found serendipitously has increased such that now up to 70 percent of kidney cancers are discovered incidentally.
Scripps research scientists determine structure of immune molecule that counteracts HIV strains
May 31, 2010 by admin · Leave a Comment
Contact: Keith McKeown
kmckeown@scripps.edu
858-784-8134
Scripps Research Institute Read more
Blocking DNA repair protein could lead to targeted, safer cancer therapy
May 31, 2010 by admin · Leave a Comment
Contact: Anita Srikameswaran
SrikamAV@upmc.edu
412-578-9193
University of Pittsburgh Schools of the Health Sciences
PITTSBURGH, June 1 Researchers at the University of Pittsburgh Cancer Institute (UPCI) and the School of Medicine have discovered that inhibiting a key molecule in a DNA repair pathway could provide the means to make cancer cells more sensitive to radiation therapy while protecting healthy cells.
Only 5 percent of cancer research funds are spent on metastases, yet it kills 90 percent of all cancer patients
Contact: Emma Mason
wordmason@mac.com
ECCO-the European CanCer Organisation
On average, about five percent of total cancer research funding is spent on investigating metastases (the spread of cancer cells around the body) in Europe, yet metastatic disease is the direct or indirect cause of 90 percent of all cancer deaths, according to an editorial in the European Journal of Cancer (EJC). [1]
Nottingham research leads to blood test for early detection of cancer
May 31, 2010 by admin · Leave a Comment
Contact: Lindsay Brooke
lindsay.brooke@nottingham.ac.uk
44-115-951-5751
University of Nottingham
The University of Nottingham spin-out company, Oncimmune Ltd, has developed a ground breaking blood test which will aid the detection of cancer as much as five years earlier than current testing methods such as mammography and CT scans. Physicians will know the result of their patient’s test within one week of sending in a blood sample to Oncimmune.
Making enough red blood cells
Contact: Sonia Furtado
sonia.furtado@embl.de
European Molecular Biology Laboratory Read more
